These updates are republished press releases and communications from members of the Science|Business Network
Trinity researchers secure government funding for next generation therapies for incurable cancers
Researchers at the Trinity Translational Medicine Institute (TTMI) are part of a successful consortium to secure €6.8M government funding as part of a 3-year, €10.5M programme to develop next generation cell therapies for cancer.
The HEALED consortium is one of 29 projects that the government has funded under the Disruptive Technologies Innovation Fund (DTIF) which is managed and funded through the Department of Enterprise and Innovation (DBEI) in Ireland.
The research team at TTMI at St James’s Hospital have partnered with RemedyBio, aCGT Vector DAC and the SFI Centre for Research Training (CRT) in Genomics Data Science at NUIG to create the HEALED Consortium
The selected projects will receive a total of €95m over the next three years.
These include technologies that aim to improve outcomes for cancer patients, projects that use drones to detect drug smuggling and projects that use artificial intelligence to make factories safer.
So far, €235m has been allocated out of the total fund of €500m.
Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar said his department is funding projects which will have wide-ranging benefits across many areas of society. There are many successful projects in the health sector, which we hope will result in better patient outcomes for thousands suffering from cancer, heart disease and fractured bones among other conditions.